
BioAssemblyBot® 200 delivers advanced, automated biofabrication in a compact benchtop design. Built for modern labs where space and speed matter, it brings 3D bioprinting, liquid handling, and material manipulation together in one streamlined system, making it easier to scale organoid research, NAMs, and tissue engineering without sacrificing precision or capability.


BioAssemblyBot® 200 Key Specifications
-
Compact benchtop design for space-efficient lab integration
-
4-axis robotic arm for automated biofabrication workflows
-
Supports up to 5 BioAssemblyBot Hands in a single run
-
3D bioprinting, liquid handling, and material manipulation in one platform
-
Build volume: 11 in × 7 in × 2.75 in
-
Advanced temperature control for hot, cold, and ambient biofabrication workflows
-
Pneumatic or mechanical dispensing capability
-
Designed for sterile operation with optional HEPA filtration
-
Compatible with standard lab utilities and existing lab infrastructure
-
Engineered for organoids, NAMs, vascularization, and tissue engineering applications

BioAssemblyBot200 Features
BioAssemblyBot 200 Key Features & Specifications:

HEPA Filtration System
UL cGMP Certified
4-Axis Robotic Arm
Use up to 5 compatible BioAssemblyBot Hands
Adaptive Tip Detection
Temperature Controlled Print Stage
Required electrical cabinet and touch screen interface not shown.
The BioAssemblyBot® is engineered to meet the world's highest standards for safety, quality, and regulatory compliance. It is UL Certified and conforms to IEC/EN 61010-1 Laboratory Safety and IEC/EN 61326-1 Electromagnetic Compatibility (EMC) standards, while carrying CE Marking for global market readiness. The platform is designed to support cGMP manufacturing environments and complies with California Proposition 65, RoHS, REACH, and WEEE requirements—ensuring safe, reliable operation and environmental compliance for laboratories around the world.

The Advanced Solutions Louisville, KY facility has been audited by UL Registrar LLC and meets GMP requirements listed in RCP, NBCP, or Pharmaceutical Certification Schemes which is uniquely accredited by the American National Standard Institute (ANSI) developed in accordance with applicable sections of the FDA’s code of federal regulations.






